Hybrid antibodies can target sites for attack by T cells.
about
"Diabodies": small bivalent and bispecific antibody fragmentsBispecific antibodies for cancer therapy: the light at the end of the tunnel?Site-specific functionalization of proteins and their applications to therapeutic antibodiesNovel immunotherapies for hematologic malignanciesBispecific T-cell engagers for cancer immunotherapy.Cell-mediated fas-based lysis of dendritic cells which are apparently resistant to anti-Fas antibodyComparative and evolutionary analysis of α-amylase gene across monocots and dicots.Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatmentGrafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR.Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cellsDesign and applications of bispecific heterodimers: molecular imaging and beyondA small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity.Bispecific antibodies engage T cells for antitumor immunotherapy.Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection.Antigen-receptor interaction requirement for conjugate formation and lethal-hit triggering by cytotoxic T lymphocytes can be bypassed by protein kinase C activators and Ca2+ ionophores.Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates.Purified anti-CD3 × anti-HER2 bispecific antibody potentiates cytokine-induced killer cells of poor spontaneous cytotoxicity against breast cancer cellsCurrent approaches to vaccine preparation.Optically induced cell fusion using bispecific nanoparticles.Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.Synthesis of bispecific antibodies using genetically encoded unnatural amino acids.Novel monoclonal antibodies for cancer treatment: the trifunctional antibody catumaxomab (removab).Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells.Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.Activation of human peripheral blood mononuclear cells by anti-T3: killing of tumor target cells coated with anti-target-anti-T3 conjugatesLarge-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle.Introduction to monoclonal antibodies.Symmetry breaking: bispecific antibodies, the beginnings, and 50 years onHighly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient miceConcanamycin A, a vacuolar type H(+)-ATPase inhibitor, induces cell death in activated CD8(+) CTL.Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies.Antigen receptor-regulated exocytosis in cytotoxic T lymphocytes.Murine T cells express a cell surface receptor for multiple extracellular matrix proteins. Identification and characterization with monoclonal antibodies.Triggering T cells by otherwise inert hybrid anti-CD3/antitumor antibodies requires encounter with the specific target cell.Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain.Hybrid antibody mediated veto of cytotoxic T lymphocyte responses.Biodistribution studies with tumor-targeting bispecific antibodies reveal selective accumulation at the tumor siteA soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations.Development of a novel bi-specific monoclonal antibody approach for tumour targeting.Target cell death triggered by cytotoxic T lymphocytes: a target cell mutant distinguishes passive pore formation and active cell suicide mechanisms
P2860
Q24562167-F0CC4522-CEAF-4C94-ACFC-7C58DEDFF484Q24644083-170470C1-1D99-4764-8B91-55EDA470E4DEQ26830699-2C6B8E69-CEC1-424F-8EED-31321BBF94ECQ27004436-C21663B9-9C8C-4974-9391-D0F75192A7D9Q27693313-6CA1DF80-6786-41F7-841C-FDDB52940BCEQ28506177-43ECD504-DBA3-4063-89CC-F791CD21EB3CQ30391314-EB3656FC-53FC-4010-8A9D-957D2428BA98Q30445571-39EBBCE1-F9A4-4EAD-A82A-797A082B792AQ33181048-F020B78C-A115-4110-B400-8C74EC0A934DQ33656364-FA13D9A6-420F-4DAE-A50B-7B7410D4E077Q33732587-F5546D84-CAB1-41E0-A78E-D3BD5B74D26FQ34096268-1C76346E-54B2-4A03-81A2-73FF14C38A74Q34174334-C64B9E07-ECF8-40A1-82EB-CAAE1EB5B4FFQ34517676-BF3F6E4F-5D07-494D-BF46-CB02A728F14AQ34601961-F1A298BE-BCE8-4F0A-9543-BC256C0F5D6EQ34636353-DA41EC25-EBBD-4D75-812C-2026F52CB5D0Q34643044-706DED40-A420-430B-96C2-BBACFD9A336CQ34688016-CCA08F1D-C447-4D28-AF1C-A55A1B63725AQ34780023-E8013C51-6CF2-4781-8C89-278614E3D839Q34869927-94FFC2E0-8E73-4F19-9406-BFC6AF2FD8C8Q34986422-7DAD960D-5A0B-441A-95AA-C63D0DA71DC6Q35057971-596F6208-F229-4FB6-9103-0F26358FE137Q35220077-EADCD119-C727-4AA5-9C9B-18EA8BBA30C2Q35593361-6C60785C-9750-435C-9B25-DD692A2A3B42Q35612033-03EE149F-3904-415B-8127-181F63ABFC6AQ35808466-99F19F1C-59B5-48AF-AB04-591933885EBEQ36050008-B7DBD00E-9637-4E8B-A052-7F90F6DD714BQ36050013-1CECC5A1-338D-476A-95ED-421ED578A3E3Q36202548-2C7E0E56-74A4-4238-9FCE-55B39C97C80FQ36304657-17D3971A-9375-432E-BD1B-4C23D70B24B5Q36351487-A942C55E-4761-49D7-ABCB-391ED9C02821Q36353869-5BFF290D-94D6-49F8-B0BF-49D4344FD72EQ36356393-4E258D02-0EE6-495F-8B85-7B6E9A9DE765Q36356552-13827011-B146-4BD1-BEE4-6FA2D362175CQ36361920-108AE72F-FFB6-46A5-BA3D-CF87AED9A226Q36366611-EDF3A048-CEB8-4D94-A4AF-CF34304FAC88Q36411863-F7F5AFBD-CD74-4994-A380-407751AFCF8AQ36424948-392E5AA2-677D-4E83-B2E2-B0022C49C14BQ36619778-74AB39C4-9712-47B9-8FEA-B79B0BEF04F7Q36643636-22E82BF9-3E55-4BEE-9B5F-6219F8D932B0
P2860
Hybrid antibodies can target sites for attack by T cells.
description
1985 nî lūn-bûn
@nan
1985 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Hybrid antibodies can target sites for attack by T cells.
@ast
Hybrid antibodies can target sites for attack by T cells.
@en
Hybrid antibodies can target sites for attack by T cells.
@nl
type
label
Hybrid antibodies can target sites for attack by T cells.
@ast
Hybrid antibodies can target sites for attack by T cells.
@en
Hybrid antibodies can target sites for attack by T cells.
@nl
prefLabel
Hybrid antibodies can target sites for attack by T cells.
@ast
Hybrid antibodies can target sites for attack by T cells.
@en
Hybrid antibodies can target sites for attack by T cells.
@nl
P2093
P356
P1433
P1476
Hybrid antibodies can target sites for attack by T cells.
@en
P2093
P2888
P304
P356
10.1038/314628A0
P407
P577
1985-04-01T00:00:00Z
P6179
1011668037